In this video, Gary R. Lichtenstein, MD, describes the implementation of the Penn IBD­-Cancer Prevention Formula, which combines accurate risk identification and detection of precancerous conditions with effective preventative strategies to arrive at an outcome of interest-reduced cancer incidence, less mortality, fewer colectomies and improved health­related quality of life.

In describing the Formula, Dr. Lichtenstein delves into improvements in dysplasia detection in IBD; image enhanced endoscopy techniques; intra­procedural variables; factors affecting the success of surveillance colonoscopy and the idiosyncrasies of the dysplasia­associated lesion or mass (DALM) among other topics. Includes procedural videos demonstrating polypectomy and chromoendoscopy.

Related Links

• Innovations in IBD Therapy at Penn Medicine
• Dr. Lichtenstein’s Profile